These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 36913642

  • 1. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black P, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Luo C, Li M, Hu B.
    J Clin Oncol; 2023 Jun 01; 41(16):3009-3018. PubMed ID: 36913642
    [Abstract] [Full Text] [Related]

  • 2. Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
    Tachibana I, Alabd A, Tong Y, Piroozi A, Mahmoud M, Kern SQ, Masterson TA, Adra N, Foster RS, Hanna NH, Einhorn LH, Cary C.
    J Clin Oncol; 2023 Aug 10; 41(23):3930-3938. PubMed ID: 36730902
    [Abstract] [Full Text] [Related]

  • 3. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.
    Hu B, Shah S, Shojaei S, Daneshmand S.
    Clin Genitourin Cancer; 2015 Aug 10; 13(4):e265-e269. PubMed ID: 25682512
    [Abstract] [Full Text] [Related]

  • 4. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    Matulewicz RS, Benfante N, Funt SA, Feldman DR, Carver B, Doudt A, Knezevic A, Sheinfeld J.
    J Urol; 2024 Jan 10; 211(1):80-89. PubMed ID: 37672753
    [Abstract] [Full Text] [Related]

  • 5. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
    Hiester A, Che Y, Lusch A, Kuß O, Niegisch G, Lorch A, Arsov C, Albers P.
    Eur Urol; 2023 Jul 10; 84(1):25-31. PubMed ID: 36372627
    [Abstract] [Full Text] [Related]

  • 6. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
    Nicolai N, Nazzani S, Tesone A, Macchi A, Piva L, Salvioni R, Stagni S, Torelli T, Agostini E, Celso F, Giannatempo P, Procopio G, Avuzzi B, Lanocita R, Cattaneo L, Catanzaro M, Biasoni D.
    Tumori; 2023 Aug 10; 109(4):379-386. PubMed ID: 35915559
    [Abstract] [Full Text] [Related]

  • 7. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.
    Liu J, Thomas B, Lawrentschuk N.
    Eur Urol; 2023 Oct 10; 84(4):438-439. PubMed ID: 37385842
    [No Abstract] [Full Text] [Related]

  • 8. Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
    Tachibana I, Kern SQ, Douglawi A, Tong Y, Mahmoud M, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C.
    J Clin Oncol; 2022 Nov 10; 40(32):3762-3769. PubMed ID: 35675585
    [Abstract] [Full Text] [Related]

  • 9. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL.
    Clin Genitourin Cancer; 2020 Apr 10; 18(2):e194-e201. PubMed ID: 31818649
    [Abstract] [Full Text] [Related]

  • 10. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME, Eggener SE.
    Eur Urol; 2017 Mar 10; 71(3):476-482. PubMed ID: 27234998
    [Abstract] [Full Text] [Related]

  • 11. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
    Heidenreich A, Paffenholz P, Hartmann F, Seelemeyer F, Pfister D.
    Eur Urol Oncol; 2024 Feb 10; 7(1):122-127. PubMed ID: 37438222
    [Abstract] [Full Text] [Related]

  • 12. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.
    Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR.
    Urology; 2003 Aug 10; 62(2):324-7. PubMed ID: 12893344
    [Abstract] [Full Text] [Related]

  • 13. The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma.
    Sigg S, Fankhauser CD.
    Curr Opin Urol; 2023 Jul 01; 33(4):245-251. PubMed ID: 37144886
    [Abstract] [Full Text] [Related]

  • 14. Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.
    Tachibana I, Alabd A, Whaley RD, McFadden J, Piroozi A, Hassoun R, Kern SQ, King J, Adra N, Rice KR, Foster RS, Einhorn LH, Cary C, Masterson TA.
    Urol Oncol; 2023 Sep 01; 41(9):394.e1-394.e6. PubMed ID: 37543446
    [Abstract] [Full Text] [Related]

  • 15. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
    Notarfrancesco M, Fankhauser CD, Lorch A, Ardizzone D, Helnwein S, Hoch D, Hermanns T, Thalmann G, Beyer J.
    Swiss Med Wkly; 2023 Apr 10; 153():40053. PubMed ID: 37080191
    [Abstract] [Full Text] [Related]

  • 16. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.
    Patel HD, Joice GA, Schwen ZR, Semerjian A, Alam R, Srivastava A, Allaf ME, Pierorazio PM.
    World J Urol; 2018 Jan 10; 36(1):73-78. PubMed ID: 29026972
    [Abstract] [Full Text] [Related]

  • 17. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
    Werntz RP, Pearce SM, Eggener SE.
    Curr Opin Urol; 2018 Sep 10; 28(5):461-468. PubMed ID: 29979235
    [Abstract] [Full Text] [Related]

  • 18. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM, Cheaib JG, Patel HD, Gupta M, Sharma R, Zhang A, Tema G, Bass EB.
    J Urol; 2021 Feb 10; 205(2):370-382. PubMed ID: 32915080
    [Abstract] [Full Text] [Related]

  • 19. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A, Nini A, Arsov C, Buddensieck C, Albers P.
    J Urol; 2020 Dec 10; 204(6):1242-1248. PubMed ID: 32717162
    [Abstract] [Full Text] [Related]

  • 20. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S, Patel M, Porter J.
    Eur Urol; 2016 Oct 10; 70(4):661-667. PubMed ID: 27068395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.